share_log

Dawson James Initiates Coverage On Zomedica With Buy Rating, Announces Price Target of $6

Dawson James Initiates Coverage On Zomedica With Buy Rating, Announces Price Target of $6

道森詹姆斯授予zomedica買入評級,並宣佈目標價爲$6
Benzinga Real-time News ·  2023/01/06 21:27

Dawson James analyst Jason Kolbert initiates coverage on Zomedica (AMEX:ZOM) with a Buy rating and announces Price Target of $6.

道森詹姆斯分析師Jason Kolbert開始對zomedica(美交所:ZOM)發起買入評級,並宣佈目標股價爲6美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論